Improved serological detection of rheumatoid arthritis: A highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display

Arthritis Research and Therapy

Volumn 17, Issue 1, 2015, Pages

  Araujo, Galber Rodrigues ^a,b   Vaz, Emília Rezende ^a   Fujimura, Patricia Tiemi ^a   Fonseca, João Eurico ^c,d   de Lima, Lucélia Maria ^a   Canhão, Helena ^c,d   Venturini, Gabriela ^e   Cardozo, Karina Helena Morais ^f   Carvalho, Valdemir Melechco ^f   Napimoga, Marcelo Henrique ^g   Goulart, Luiz Ricardo ^a,h   Gonçalves, João ^b,i   Ueira Vieira, Carlos ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^d HOSPITAL DE SANTA MARIA   (Portugal)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f Fleury   (Brazil)

^g SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BIOLOGICAL MARKER; CARBONATE DEHYDRATASE III; IMMUNOGLOBULIN G; M12 PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKYLOSING SPONDYLITIS; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MOLECULAR CLONING; MOLECULAR DIAGNOSIS; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PHAGE DISPLAY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; WESTERN BLOTTING; AGED; AMINO ACID SEQUENCE; ANIMAL; ARTHRITIS, RHEUMATOID; BLOOD; CELL SURFACE DISPLAY; DBA MOUSE; DISEASE MODEL; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; MOLECULAR MIMICRY; PHYSIOLOGY; PROCEDURES; PROTEIN SECONDARY STRUCTURE;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; CARBONIC ANHYDRASE III; CELL SURFACE DISPLAY TECHNIQUES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED DBA; MIDDLE AGED; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY;

EID: 84935432092     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-015-0685-3     Document Type: Article

References (77)

1. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2005;72:1037-47.
2. National Collaborating Centre for Chronic Conditions (UK). Rheumatoid Arthritis: National Clinical Guideline for Management and Treatment in Adults. London: Royal College of Physicians; 2009.
3. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol. 2011;7:391-8.
4. van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2002;60:383-8.
5. Rantapaa-Dahlqvist S. Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol. 2005;34:83-96.
6. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155-63.
7. Coenen D, Verschueren P, Westhovens R, Bossuyt X. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem. 2007;53:498-504.
8. Vander Cruyssen B, Cantaert T, Nogueira L, Clavel C, De Rycke L, Dendoven A, et al. Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays. Arthritis Res Ther. 2006;8:R122.
9. Goeb V, Jouen F, Gilbert D, Le Loet X, Tron F, Vittecoq O. Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint Bone Spine. 2009;76:343-9.
10. Taylor P, Gartemann J, Hsieh J, Creeden J. A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis. 2011;2011:815038.
11. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 2005;7:R949-58.
12. Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis. 2008;67:212-7.
13. Mjaavatten MD, van der Heijde DM, Uhlig T, Haugen AJ, Nygaard H, Bjorneboe O, et al. Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study. J Rheumatol. 2011;38:2336-41.
14. Park KH, Mun CH, Kang MI, Lee SW, Lee SK, Park YB. Treatment of collagen-induced arthritis using immune modulatory properties of human mesenchymal stem cells. Cell Transpl. 2015. doi: 10.3727/096368915X687949 .
15. Chow LN, Choi KY, Piyadasa H, Bossert M, Uzonna J, Klonisch T, et al. Human cathelicidin LL-37-derived peptide IG-19 confers protection in a murine model of collagen-induced arthritis. Mol Immunol. 2014;57:86-92.
16. Eneljung T, Tengvall S, Jirholt P, Henningsson L, Holmdahl R, Gustafsson K, et al. Antigen-specific gene therapy after immunisation reduces the severity of collagen-induced arthritis. Clin Dev Immunol. 2013;2013:345092.
17. Ding X, Hu J, Li J, Zhang Y, Shui B, Ding Z, et al. Metabolomics analysis of collagen-induced arthritis in rats and interventional effects of oral tolerance. Anal Biochem. 2014;458:49-57.
18. Rosloniec EF, Cremer M, Kang AH, Myers LK, Brand DD. Collagen-induced arthritis. Curr Protoc Immunol. 2010;89:15.5:15.5.1-15.5.25.
19. Wang M, Li X, Chen J, Zhou Y, Cao H, Wu X, et al. Screening and evaluating the mimic peptides as a useful serum biomarker of ankylosing spondylitis using a phage display technique. Rheumatol Int. 2011;31:1009-16.
20. Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev. 2006;58:1622-54.
21. Samoylova TI, Morrison NE, Globa LP, Cox NR. Peptide phage display: opportunities for development of personalized anti-cancer strategies. Anticancer Agents Med Chem. 2006;6:9-17.
22. Alves PT, Fujimura PT, Morais LD, Goulart LR. Revisiting the CD14: epitope mapping by phage display. Immunobiology. 2014;219:822-9.
23. Reis CF, Carneiro AP, Vieira CU, Fujimura PT, Morari EC, Silva SJ, et al. An antibody-like peptide that recognizes malignancy among thyroid nodules. Cancer Lett. 2013;335:306-13.
24. Santos PS, Sena AA, Nascimento R, Araujo TG, Mendes MM, Martins JR, et al. Epitope-based vaccines with the Anaplasma marginale MSP1a functional motif induce a balanced humoral and cellular immune response in mice. PLoS One. 2013;8:e60311.
25. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science. 1990;249:386-90.
26. Huang J, Ru B, Dai P. Bioinformatics resources and tools for phage display. Molecules. 2011;16:694-709.
27. Somers K, Geusens P, Elewaut D, De Keyser F, Rummens JL, Coenen M, et al. Novel autoantibody markers for early and seronegative rheumatoid arthritis. J Autoimmun. 2011;36:33-46.
28. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8.
29. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nat Protoc. 2007;2:1269-75.
30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
31. O'Valle F, Peregrina M, Crespo-Lora V, Galindo-Moreno P, Roman M, Padial-Molina M, et al. Osteoarticular expression of Musashi-1 in an Experimental model of arthritis. Biomed Res Int. 2015; Article ID 681456, in press.
32. BD Barbas CF, Scott JK, Silverman GJ. Phage display: a laboratory manual. NY: Cold Spring Harbor Laboratory Press; 2001.
33. Stothard P. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques. 2000;28:1102-4.
34. Artimo P, Jonnalagedda M, Arnold K, Baratin D, Csardi G, de Castro E, et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res. 2012;40:W597-603.
35. ExPASy Proteomics and Sequence Analysis tool. http://web.expasy.org/translate/ .
36. ClustalW2 online server. http://www.ebi.ac.uk/Tools/msa/clustalw2/ .
37. Mayrose I, Penn O, Erez E, Rubinstein ND, Shlomi T, Freund NT, et al. Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics. 2007;23:3244-6.
38. The Pepitope Server. http://pepitope.tau.ac.il/ .
39. Immune Epitope Database and Analysis Resource. http://www.iedb.org/ .
40. Pymol. http://www.pymol.org .
41. Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276:172-4.
42. Kolaskar and Tongaonkar antigenicity scale. http://tools.immuneepitope.org/bcell/ .
43. Camargo M, Intasqui Lopes P, Del Giudice PT, Carvalho VM, Cardozo KH, Andreoni C, et al. Unbiased label-free quantitative proteomic profiling and enriched proteomic pathways in seminal plasma of adult men before and after varicocelectomy. Hum Reprod. 2013;28:33-46.
44. Casey JL, Coley AM, Street G, Parisi K, Devine PL, Foley M. Peptide mimotopes selected from a random peptide library for diagnosis of Epstein-Barr virus infection. J Clin Microbiol. 2006;44:764-71.
45. Williams RO. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha. Methods Mol Biol. 2007;361:265-84.
46. Corthay A, Hansson AS, Holmdahl R. T lymphocytes are not required for the spontaneous development of entheseal ossification leading to marginal ankylosis in the DBA/1 mouse. Arthritis Rheum. 2000;43:844-51.
47. Eros G, Ibrahim S, Siebert N, Boros M, Vollmar B. Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis. Arthritis Res Ther. 2009;11:R43.
48. Chiba A, Mizuno M, Tomi C, Tajima R, Alloza I, di Penta A, et al. A 4-trifluoromethyl analogue of celecoxib inhibits arthritis by suppressing innate immune cell activation. Arthritis Res Ther. 2012;14:R9.
49. Hong SH, Kwone JT, Lee JH, Lee S, Lee AY, Cho WY, et al. Ascidian tunicate extracts attenuate rheumatoid arthritis in a collagen-induced murine model. Nat Prod Commun. 2014;9:847-51.
50. Mural RJ, Adams MD, Myers EW, Smith HO, Miklos GL, Wides R, et al. A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science. 2002;296:1661-71.
51. Weng X, Liao Q, Li K, Li Y, Mi M, Zhong D. Screening serum biomarker of knee osteoarthritis using a phage display technique. Clin Biochem. 2012;45:303-8.
52. Costa LE, Lima MI, Chavez-Fumagalli MA, Menezes-Souza D, Martins VT, Duarte MC, et al. Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications. Clin Vaccine Immunol. 2014;21:96-106.
53. Derda R, Tang SK, Li SC, Ng S, Matochko W, Jafari MR. Diversity of phage-displayed libraries of peptides during panning and amplification. Molecules. 2011;16:1776-803.
54. Kuzmicheva GA, Jayanna PK, Sorokulova IB, Petrenko VA. Diversity and censoring of landscape phage libraries. Protein Eng Des Sel. 2009;22:9-18.
55. Rodi DJ, Soares AS, Makowski L. Quantitative assessment of peptide sequence diversity in M13 combinatorial peptide phage display libraries. J Mol Biol. 2002;322:1039-52.
56. Rodi DJ, Makowski L. Structure and Function of Macromolecular Assembly. Matsushita: Japan; 1997.
57. Edwards YH, Tweedie S, Lowe N, Lyons G. Carbonic anhydrase 3 (CA3), a mesodermal marker. Symp Soc Exp Biol. 1992;46:273-83.
58. Robert-Pachot M, Desbos A, Moreira A, Becchi M, Tebib J, Bonnin M, et al. Carbonic anhydrase III: a new target for autoantibodies in autoimmune diseases. Autoimmunity. 2007;40:380-9.
59. Liu C, Wei Y, Wang J, Pi L, Huang J, Wang P. Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure. Clin Dev Immunol. 2012;2012:354594.
60. Srinivasan P, Kumar SP, Karthikeyan M, Jeyakanthan J, Jasrai YT, Pandya HA, et al. Epitope-based immunoinformatics and molecular docking studies of nucleocapsid protein and ovarian tumor domain of crimean-congo hemorrhagic fever virus. Front Genet. 2011;2:72.
61. Ranjbar MM, Ghorban K, Alavian SM, Keyvani H, Dadmanesh M, Roayaei Ardakany A, et al. GB virus C/hepatitis G virus envelope glycoprotein E2: computational molecular features and immunoinformatics study. Hepat Mon. 2013;13:e15342.
62. Sealey KL, Kirk RS, Walker AJ, Rollinson D, Lawton SP. Adaptive radiation within the vaccine target tetraspanin-23 across nine Schistosoma species from Africa. Int J Parasitol. 2013;43:95-103.
63. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet. 2006;7:61-80.
64. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B, Group BS. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004;63:1090-5.
65. Herold M, Boeser V, Russe E, Klotz W. Anti-CCP: history and its usefulness. Clin Dev Immunol. 2005;12:131-5.
66. Wagner E, Skoumal M, Bayer PM, Klaushofer K. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis. Rheumatol Int. 2009;29:1315-21.
67. Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden AI. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol. 2009;36:491-500.
68. Fernandez-Suarez A, Reneses S, Wichmann I, Criado R, Nunez A. Efficacy of three ELISA measurements of anti-cyclic citrullinated peptide antibodies in the early diagnosis of rheumatoid arthritis. Clin Chem Lab Med. 2005;43:1234-9.
69. Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, et al. Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clin Rheumatol. 2007;26:1627-33.
70. van Gaalen FA, Visser H, Huizinga TW. A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis. Ann Rheum Dis. 2005;64:1510-2.
71. Kim S, Kim JH, Lee JH, Kim HS. Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects. Rheumatology. 2010;49:450-7.
72. Binesh F, Salehabadi HS, Behniafard N, Ranginkaman K, Behniafard N. A comparative assessment of the diagnostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis. J Clin Exp Pathol. 2014;4:158. doi: 10.4172/2161-0681.1000158 .
73. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146:797-808.
74. Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis. 2005;64:1731-6.
75. Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study. Ann Rheum Dis. 2010;69:1333-7.
76. Mikuls TR, O'Dell JR, Stoner JA, Parrish LA, Arend WP, Norris JM, et al. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis Rheum. 2004;50:3776-82.
77. Vermeer M, Kuper HH, Hoekstra M, Haagsma CJ, Posthumus MD, Brus HL, et al. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study. Arthritis Rheum. 2011;63:2865-72.